Who owns SALARIUS PHARMACEUTICALS INC?
- Ticker: SLRX
- CUSIP Number: 79400x305
Tip: Access positions for across all investors
Analyze quarterly positions in Salarius Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Salarius Pharmaceuticals stock
Who bought or sold SALARIUS PHARMACEUTICALS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Armistice Capital | 225k | $148k | 105% | Sep 2023 |
|
Horizon Kinetics Asset Management | 31k | $20k | -4% | Dec 2023 |
|
Geode Capital Management | 25k | $16k | 50% | Sep 2023 |
|
Citadel Advisors | 25k | $16k | 100% | Dec 2023 |
|
Renaissance Technologies | 24k | $16k | 18% | Sep 2023 |
|
Vanguard Group | 15k | $9.5k | 2% | Dec 2023 |
|
Susquehanna International | 14k | $9.1k | 31% | Sep 2023 |
|
Two Sigma Securities | 13k | $8.4k | 100% | Dec 2023 |
|
Tower Research Capital | 8.2k | $5.4k | 0% | Sep 2023 |
|
Advisor Group Holdings | 1.4k | $899.885600 | 0% | Dec 2023 |
|
Morgan Stanley | 220.00 | $145.002000 | 0% | Sep 2023 |
|
UBS Group | 78.00 | $50.996400 | 0% | Dec 2023 |
|
FMR | 49.00 | $32.001900 | 4800% | Sep 2023 |
|
BlackRock | 47.00 | $30.841400 | 0% | Sep 2023 |
|
Wells Fargo & Company | 30.00 | $20.001000 | 11% | Dec 2023 |
|
Bank of America Corporation | 16.00 | $10.000000 | -50% | Dec 2023 |
|